Foghorn Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Foghorn Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Foghorn Therapeutics Inc
Rating: 1.61566675
Author: Trendlyne DVM scores

about

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin r...

5.95 -0.06 (-1.00%)

81.96% Gain from 52W Low

293.9K

XNAS Volume

XNAS 10 Jul, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

6.7 / 100

Technically Neutral

58.0 / 100

1Yr Price target upside is 92%

9 analysts

Foghorn Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Foghorn Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin r...

81.96% Gain from 52W Low

SWOT Analysis

Foghorn Therapeutics Inc Live Price Chart

Foghorn Therapeutics Inc Live Price Chart